This antibody is intended for in vitro diagnostic (IVD) use. Ventana Medical Systems, Inc. (Ventana) CONFIRM anti-LMO2 (1A9-1) Mouse Monoclonal Primary Antibody is designed to qualitatively detect the presence of LMO2 expressing cells via light microscopy in formalin fixed, paraffin embedded tissue. Positive staining results may aid in the classification of B-cell lymphomas. The clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests.
This may be a regulated product; it may not be available in all geographies. Please consult your local representative for availability and restrictions. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.